Literature DB >> 11998534

Fate of abstracts presented at five International Conferences on Pharmacoepidemiology (ICPE): 1995-1999.

P Stolk1, A C G Egberts, H G M Leufkens.   

Abstract

BACKGROUND: Meetings are an important way of exchanging scientific information, but full diffusion of new information can only be achieved when results are published in scientific journals.
PURPOSE: (1) To determine the publication frequency of accepted abstracts for the yearly international conferences on pharmacoepidemiology (ICPE) and to examine predicting variables; (2) if published, to determine impact differences between 'oral' and 'poster' abstracts and to determine type and nature of publishing journals.
METHODS: Abstracts accepted for ICPE 1995-1999, published in the official conference supplement of Pharmacoepidemiology and Drug Safety, were included. Publication status for the information contained in each abstract was evaluated through MEDLINE and IPA searches. Impact factors of publishing journals were retrieved and journals were included in one of five groups.
RESULTS: Overall, one out of three abstracts resulted in a publication in the peer-reviewed journals studied. Abstracts from North America were more often presented orally than abstracts from Europe, but had lower publication chances. 'Oral' abstracts were more likely to be published than 'poster' abstracts; abstracts with a strong methodological content had a lower publication frequency. Most of the published abstracts were found in pharmacology and pharmacy journals (33%) and journals on specific clinical topics (30%).
CONCLUSIONS: Only one out of three papers presented at ICPE ends up in established peer-reviewed journals. Although the publication characteristics for ICPE are not very different from other conferences, there are certain questions that warrant further investigation.

Mesh:

Year:  2002        PMID: 11998534     DOI: 10.1002/pds.687

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  8 in total

1.  Scientific papers presented at the European Congress of Radiology 2000: publication rates and characteristics during the period 2000-2004.

Authors:  Alberto Miguel-Dasit; Luis Martí-Bonmatí; Pilar Sanfeliu; Rafael Aleixandre
Journal:  Eur Radiol       Date:  2005-07-30       Impact factor: 5.315

2.  Fate of the abstracts presented at three Spanish clinical pharmacology congresses and reasons for unpublished research.

Authors:  E Montané; X Vidal
Journal:  Eur J Clin Pharmacol       Date:  2007-02       Impact factor: 2.953

3.  Fate of abstracts presented at the annual meeting of the korean urological association.

Authors:  Jae Hoon Chung; Riccardo Autorino; Dong Hyuk Kang; Joo Yong Lee; Hong Sang Moon; Hong Yong Choi; Seung Wook Lee
Journal:  Korean J Urol       Date:  2012-04-18

4.  Predictors of Publication Rates for Abstracts Presented at the American Association of Colleges of Pharmacy Annual Meetings.

Authors:  Samantha Spencer; Chloe Majkowski; Katie J Suda
Journal:  Am J Pharm Educ       Date:  2018-10       Impact factor: 2.047

5.  Publication rate of abstracts orally presented at the Turkish Society of Anaesthesiology and Reanimation National Congresses.

Authors:  Büşra Tok Çekmecelioğlu; Betül Kozanhan; Gülay Eren
Journal:  Turk J Anaesthesiol Reanim       Date:  2019-01-29

6.  Frequency and factors influencing publication of abstracts presented at three major nephrology meetings.

Authors:  Ziv Harel; Ron Wald; Ari Juda; Chaim M Bell
Journal:  Int Arch Med       Date:  2011-12-06

7.  Full publication of results initially presented in abstracts.

Authors:  Roberta W Scherer; Joerg J Meerpohl; Nadine Pfeifer; Christine Schmucker; Guido Schwarzer; Erik von Elm
Journal:  Cochrane Database Syst Rev       Date:  2018-11-20

8.  An analysis of abstracts presented to the college on problems of drug dependence meeting and subsequent publication in peer review journals.

Authors:  Juan Carlos Valderrama-Zurián; Máxima Bolaños-Pizarro; Francisco Jesús Bueno-Cañigral; F Javier Alvarez; José Antonio Ontalba-Ruipérez; Rafael Aleixandre-Benavent
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-11-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.